Comprehensive functional testing in fibroblasts has strong utility to diagnose mitochondrial disease.
Van Hove JLK, Friederich MW, Van Hove RA, Lee JC, Knight KM, Donovan TE, Silveira L, Ganetzky RD, Hirano M, Abdenur J, Butler MG, Cassiman D, Cohen BH, Elsea SH, Enns GM, Gahl WA, Gavrilova R, Geddes GC, Glamuzina EE, Goldstein A, Haas RH, Khan A, Kripps KA, Larson AA, Lehman AN, Lichter-Konecki U, Mayr JA, Morava E, Peterson JT, Rosenfeld JA, Saneto RP, Scaglia F, Shelkowitz E, Simon M, Smet JEG, Smith WE, Soler-Alfonso C, Tarnopolsky M, Van Coster RNA, Vanlander AV, Vermeersch P, Vockley J, Wigby K, Wolfe LA, Wortmann SB, Yang JH.
Van Hove JLK, et al. Among authors: butler mg.
EMBO Mol Med. 2026 Sep 8. doi: 10.1038/s44321-026-00497-3. Online ahead of print.
EMBO Mol Med. 2026.
PMID: 42711551
Free article.